Stephen Cartt
2016
In 2016, Stephen Cartt earned a total compensation of $3.5M as President and Chief Executive Officer at Asterias Biotherapeutics.
Compensation breakdown
| Option Awards | $2,404,099 |
|---|---|
| Salary | $378,740 |
| Stock Awards | $728,000 |
| Total | $3,510,839 |
Cartt received $2.4M in option awards, accounting for 68% of the total pay in 2016.
Cartt also received $378.7K in salary and $728K in stock awards.
Rankings
In 2016, Stephen Cartt's compensation ranked 2,626th out of 14,075 executives tracked by ExecPay. In other words, Cartt earned more than 81.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,626 out of 14,075 | 81st |
Division Manufacturing | 899 out of 5,486 | 84th |
Major group Chemicals And Allied Products | 263 out of 1,900 | 86th |
Industry group Drugs | 190 out of 1,543 | 88th |
Industry Biological Products, Except Diagnostic Substances | 43 out of 287 | 85th |
Source: SEC filing on May 1, 2017.
Cartt's colleagues
We found three more compensation records of executives who worked with Stephen Cartt at Asterias Biotherapeutics in 2016.